
|
| SAVE THE DATE | |
| Effect of metabolic changes in hepatic steatosis on drug toxicity | |
DATE: 19th November at 16:30h (CET) GUEST: Inbal Mor, PhD REGISTRATION AT THIS LINK: | |
|
She received her PhD in Biochemistry from the Hebrew University. She then joined the laboratory of Prof. Karen Vousden at the Cancer Research UK Beatson Institute in Glasgow, United Kingdom, as a postdoctoral researcher, where she investigated cancer metabolism. Upon returning to Israel as a research scientist at the Faculty of Medicine of the Technion, she shifted her research focus to the metabolic aspects of MASLD. Recently, she established her own laboratory at Ariel University, dedicated to studying how alterations in liver metabolism contribute to the development and progression of MASLD, as well as how these changes affect drug metabolism in the liver.
